Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (PACTR202607535799083) titled 'A Randomized, Double-Blind, Pharmacokinetic Similarity Study to Compare AVT32-DRL_PB with Keytruda(R) in Participants with Fully Resected Melanoma (AVT32-DRL-TPK-02)' on July 31.
Study Type: Interventional
Study Design:
Parallel: different groups receive different interventions at same time during study,Randomised,Simple randomization using a randomization table created by a computer software program,Allocation was determined by the holder of the sequence who is situated off site
Primary Sponsor: Alvotech Swiss AG
Condition:
Cancer
Cancer
Intervention:
AVT32 DRL PB
Recruitment Status: Not Recruiting
...